Terms: = Bone cancer AND PR, PGR, progesterone receptor AND Clinical Outcome
28 results:
1. Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients - results of the PALG study 'PolAZA'.
Mądry K; Lis K; Tukiendorf A; Szwedyk P; Kapelko-Słowik K; Subocz E; Gołos A; Makowska W; Masternak A; Kopińska A; Czemerska M; Zawadzka-Leska S; Rusicka P; Drozd-Sokołowska J; Wiater E; Hołojda J; Pogłódek B; Centkowski P; Waszczuk-Gajda A; Machowicz R; Hałka J; Czerw T; Basak G; Dwilewicz-Trojaczek J
Hematology; 2021 Dec; 26(1):556-564. PubMed ID: 34384334
[TBL] [Abstract] [Full Text] [Related]
2. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
Tseng WW; Barretta F; Conti L; Grignani G; Tolomeo F; Albertsmeier M; Angele MK; Rutkowski P; Skoczylas J; De Paoli A; Navarria F; Raut CP; Fairweather M; Farma JM; Nessim C; Goel N; Grignol VP; Ford SJ; Cardona K; Subhawong T; Tattersall HL; Lee RM; Hu JS; von Mehren M; Sanfilippo R; Gronchi A
Cancer; 2021 Mar; 127(5):729-738. PubMed ID: 33206381
[TBL] [Abstract] [Full Text] [Related]
3. Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Steuer CE; Wu C; Lawson DH; Kudchadkar R; Master VA; El-Rayes B; Ramalingam SS; Owonikoko TK; Harvey RD
BMC Cancer; 2019 Aug; 19(1):857. PubMed ID: 31464611
[TBL] [Abstract] [Full Text] [Related]
4. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
Napieralska A; Majewski W; Kulik R; Głowacki G; Miszczyk L
Radiat Oncol; 2018 Nov; 13(1):235. PubMed ID: 30482212
[TBL] [Abstract] [Full Text] [Related]
5. Minimal residual disease is an independent predictor for 10-year survival in CLL.
Kwok M; Rawstron AC; Varghese A; Evans PA; O'Connor SJ; Doughty C; Newton DJ; Moreton P; Hillmen P
Blood; 2016 Dec; 128(24):2770-2773. PubMed ID: 27697770
[TBL] [Abstract] [Full Text] [Related]
6. Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.
Ong SY; de Mel S; Chen YX; Ooi MG; Surendran S; Lin A; Koh LP; Linn YC; Ho AY; Hwang WY; Phipps C; Loh SM; Goh YT; Tan D; Chng WJ; Gopalakrishnan SK
Bone Marrow Transplant; 2016 Jul; 51(7):933-7. PubMed ID: 26974274
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
8. Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases.
Domínguez-Malagón HR; González-Conde E; Cano-Valdez AM; Luna-Ortiz K; Mosqueda-Taylor A
Med Oral Patol Oral Cir Bucal; 2014 Jan; 19(1):e44-8. PubMed ID: 24121902
[TBL] [Abstract] [Full Text] [Related]
9. Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.
Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
Histol Histopathol; 2012 Oct; 27(10):1315-25. PubMed ID: 22936450
[TBL] [Abstract] [Full Text] [Related]
10. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract] [Full Text] [Related]
11. Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs.
Wei S; Li Y; Siegal GP; Hameed O
Ann Diagn Pathol; 2011 Apr; 15(2):79-83. PubMed ID: 21163679
[TBL] [Abstract] [Full Text] [Related]
12. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract] [Full Text] [Related]
13. Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
van der Veldt AA; Meijerink MR; van den Eertwegh AJ; Haanen JB; Boven E
Br J Cancer; 2010 Mar; 102(5):803-9. PubMed ID: 20145618
[TBL] [Abstract] [Full Text] [Related]
14. [Primary breast lymphoma--a report of 27 cases with literature review].
Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
[TBL] [Abstract] [Full Text] [Related]
15. The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.
Racila E; Racila DM; Ritchie JM; Taylor C; Dahle C; Weiner GJ
Immunogenetics; 2006 Feb; 58(1):1-8. PubMed ID: 16465510
[TBL] [Abstract] [Full Text] [Related]
16. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
Willipinski-Stapelfeldt B; Riethdorf S; Assmann V; Woelfle U; Rau T; Sauter G; Heukeshoven J; Pantel K
Clin Cancer Res; 2005 Nov; 11(22):8006-14. PubMed ID: 16299229
[TBL] [Abstract] [Full Text] [Related]
17. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
Leppä S; Saarto T; Vehmanen L; Blomqvist C; Elomaa I
Breast Cancer Res Treat; 2005 Mar; 90(2):117-25. PubMed ID: 15803358
[TBL] [Abstract] [Full Text] [Related]
18. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
Wiedswang G; Borgen E; Kåresen R; Qvist H; Janbu J; Kvalheim G; Nesland JM; Naume B
Clin Cancer Res; 2004 Aug; 10(16):5342-8. PubMed ID: 15328170
[TBL] [Abstract] [Full Text] [Related]
19. High-dose chemotherapy and autologous stem cell transplant in women with de novo chemosensitive metastatic breast cancer.
Stemmer SM; Hardan I; Brenner HJ; Rizel S
Am J Clin Oncol; 2004 Jun; 27(3):250-5. PubMed ID: 15170143
[TBL] [Abstract] [Full Text] [Related]
20. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
[TBL] [Abstract] [Full Text] [Related]
[Next]
